Search

everythinglearnresearchcommunity

for

Search:↓

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

Skin problems are common and important signs of eating disorders and treating the eating disorder can improve these skin conditions.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Spironolactone plus finasteride reduces hirsutism more effectively.

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Disrupting Acvr1b in mice causes severe hair loss and thicker skin.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.

Finasteride effectively treats male pattern hair loss with a 1 mg daily dose.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Intense pulsed light (IPL) is an efficient and safe method for hair removal, reducing hair by about 80%.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Hormonal therapies are safe and effective for treating adult women's acne.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Melatonin may help treat PCOS symptoms in rats.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.